The upcoming launch of a new multi-cancer early detection (MCED) test, supported by the 'Achieve 1' study, signals a major strategic initiative and significant investment in AI/ML and data analytics. This creates needs for scalable cloud compute, MLOps platforms, and data infrastructure to support the product's rollout and ongoing analysis.
Filing excerpt
Also on February 26, 2026, the Company posted on the "News" section under "News & Events" on its website information regarding the completion of the interim readout of Achieve 1, the Company’s study supporting the upcoming launch of Caris Detect, its multi-cancer early detection (MCED) test.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-8kaiInvestmentGet every 8-K signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c70be723-1d6e-459c-bf7e-597b09e9968a returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "c70be723-1d6e-459c-bf7e-597b09e9968a",
"signal_type": "sec-8k",
"signal_subtype": "aiInvestment",
"detected_at": "2026-03-03T08:35:13.338+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "The upcoming launch of a new multi-cancer early detection (MCED) test, supported by the 'Achieve 1' study, signals a major strategic initiative and significant investment in AI/ML and data analytics. This creates needs for scalable cloud compute, MLOps platforms, and data infrastructure to support the product's rollout and ongoing analysis.",
"metrics": {
"timeframe": "next_quarter"
},
"summary": "Caris Life Sciences announces upcoming launch of 'Caris Detect' multi-cancer early detection test.",
"excerpts": "Also on February 26, 2026, the Company posted on the \"News\" section under \"News & Events\" on its website information regarding the completion of the interim readout of Achieve 1, the Company’s study supporting the upcoming launch of Caris Detect, its multi-cancer early detection (MCED) test.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000011/cai-20260226.htm",
"filing_date": "2026-02-26",
"filing_year": 2026,
"fiscal_year_end": "02/26",
"sales_relevance": "Target for AI vendors",
"signal_category": "technology",
"technologies_mentioned": [
"AI"
]
}
}
curl https://signals.autobound.ai/v1/signals/c70be723-1d6e-459c-bf7e-597b09e9968a \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.